US 11040091
Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function
granted A61KA61K38/51A61P
Quick answer
US patent 11040091 (Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function) held by The Regents of the University of California expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/51, A61P, A61P43/00, A61P9/00